Bioxyne Limited
- Jurisdiction
Australia - ISIN
AU000000BXN6 (BXN.AX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. Read full profile
Stock price
Fundamentals
- Net revenue
€14.39M - Gross margin
33.1% - EBIT
€348.66K - EBIT margin
2.4% - Net income
-€6.69M - Net margin
-46.5%
Statement period: - (published )
Dividends
No dividend payouts